However, although further studies will be needed to clarify the precise molecular mechanisms, we have proved the concept that functional alteration of Kir2.1 at the SR modifies the calcium dynamics, resulting in a CPVT-like clinical phenotype. The gene discussed is KCNJ2; the disease is catecholaminergic polymorphic ventricular tachycardia.